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There are suggestions of an inverse association between folate intake and serum folate levels and the risk of oral cavity and
pharyngeal cancers (OPCs), but most studies are limited in sample size, with only few reporting information on the source of
dietary folate. Our study aims to investigate the association between folate intake and the risk of OPC within the International
Head and Neck Cancer Epidemiology (INHANCE) Consortium. We analyzed pooled individual-level data from ten case–control
studies participating in the INHANCE consortium, including 5,127 cases and 13,249 controls. Odds ratios (ORs) and the corre-
sponding 95% confidence intervals (CIs) were estimated for the associations between total folate intake (natural, fortification
and supplementation) and natural folate only, and OPC risk. We found an inverse association between total folate intake and
overall OPC risk (the adjusted OR for the highest vs. the lowest quintile was 0.65, 95% CI: 0.43–0.99), with a stronger associ-
ation for oral cavity (OR50.57, 95% CI: 0.43–0.75). A similar inverse association, though somewhat weaker, was observed
for folate intake from natural sources only in oral cavity cancer (OR50.64, 95% CI: 0.45–0.91). The highest OPC risk was
observed in heavy alcohol drinkers with low folate intake as compared to never/light drinkers with high folate (OR54.05,
95% CI: 3.43–4.79); the attributable proportion (AP) owing to interaction was 11.1% (95% CI: 1.4–20.8%). Lastly, we reported
an OR of 2.73 (95% CI:2.34-3.19) for those ever tobacco users with low folate intake, compared with nevere tobacco users
and high folate intake (AP of interaction 510.6%, 95% CI: 0.41-20.8%). Our project of a large pool of case–control studies
supports a protective effect of total folate intake on OPC risk.
Oral and pharyngeal cancer (OPC) is the seventh most com-
mon cancer worldwide, with more than half a million cases
and about 300,000 deaths in 2012.1 Tobacco smoking and
alcohol consumption are predominant risk factors for OPC
although other factors, including the aspects of diet, may
affect the risk.2 In particular, a high intake of fruit and vege-
tables has been linked with a lower risk of OPC, whereas a
poor nutritional status and unbalanced diet have been related
to an elevated risk.2–4 The association between dietary habits
and OPC was investigated in the International Head and
Neck Cancer Epidemiology (INHANCE) Consortium.5 Die-
tary habits reflecting high fruit/vegetable and low red meat
intake were associated with reduced head and neck cancer
risk (per unit score increment, odds ratio [OR]5 0.90, 95%
confidence interval [CI]: 0.84–0.97).
Folate, also known as vitamin B9, is a water-soluble vita-
min and is found naturally in green leafy vegetables, cereals,
legumes and fruits. In humans, folate plays the fundamental
role of providing methyl groups for de novo deoxynucleotide
synthesis and for intracellular methylation reactions.6 Only a
few case–control studies, however, addressed the effect of
folate on OPC, with inconsistent results.7–11 Three out of the
five studies reported no relationships with risk,8,9,11 whereas
two others found an inverse association.7,10 However, all
these studies provided data on natural folate intake only.
Folate, in fact, can be derived from both plant and animal
foods (natural folate), from fortified food products and from
supplements (synthetic folate also known as folic acid).
Alcohol intake and tobacco consumption are reported to
impair folate levels.12 Alcohol perturbs the folate metabolism
by reducing folate absorption, increasing folate excretion or
inhibiting methionine synthase,13,14 whereas tobacco con-
sumption increases the folate turnover in response to the
rapid tissue proliferation or DNA repair in aerodigestive tis-
sues among smokers.15,16
As alcohol and tobacco consumption are the major risk
factors for OPC, it is worth assessing whether the effect of
folate intake on OPC risk is modified by alcohol and
tobacco,10,17,18 and whether there is evidence of interaction
between variables.
We considered, therefore, the association between folate
intake and the risk of OPC in a pooled analysis of case–con-
trol studies participating in the INHANCE Consortium,
which covers populations from Europe, North America and
Japan.
Material and Methods
Studies and participants
The INHANCE Consortium was established in 2004 and to
date includes 35 head and neck cancer case–control studies
(several of which are multicenter) for a total of 25,478 cases
and 37,111 controls (data, version 1.5).19,20 Cases included
patients with invasive tumors of the oral cavity, oropharynx,
hypopharynx, larynx, oral cavity or pharynx not otherwise
specified or overlapping as defined previously.21,22 Details on
the case–control studies, harmonizing questionnaire data and
What’s new?
Folate is essential to DNA synthesis and repair, suggesting that folate deficiency, in disrupting normal DNA processes, may
facilitate the development of certain cancers, including oral and pharyngeal cancer (OPC). The relationship between folate
intake and risk of OPC, however, is unclear. In this analysis of data from the International Head and Neck Cancer Epidemiology
(INHANCE) Consortium, high levels of folate intake were found to be inversely associated with overall OPC risk. The associa-
tion was strongest for cancer of the oral cavity. Risk of OPC was highest among heavy alcohol drinkers with low folate levels.
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data pooling methods for the INHANCE consortium have
been described previously.19,21 All the studies were performed
according to the Declaration of Helsinki and were approved
by the local ethics committees, according to the legislations
at study conduction.
In our analyses, we excluded laryngeal cancer cases and
corresponding controls.
All case–control studies in the INHANCE Consortium
were eligible for inclusion in our analysis if information on
folate intake was available from the corresponding food fre-
quency questionnaire (FFQ) for at least 80% of the subjects.
Folate and energy intakes were estimated using validated
study-specific food composition tables.23–27 The subjects who
lacked information or had inconsistent values on folate intake
from FFQ were considered as missing. The cases were
divided according to the following anatomic sites: (i) oral
cavity (including lip, tongue, gum, floor of mouth and hard
palate); (ii) oropharynx (including base of tongue, lingual
tonsil, soft palate, uvula, tonsil and oropharynx) and hypo-
pharynx (including pyriform sinus and hypopharynx); (iii)
oral cavity, pharynx unspecified or overlapping (not other-
wise specified, NOS). The main characteristics of the ten eli-
gible studies are summarized in Table 1, including 5,127
cases of oral cavity/pharyngeal cancer (1,613 of the oral cav-
ity, 2,571 of oropharynx/hypopharynx and 943 of oral cavity/
pharynx NOS) and 13,249 controls.28–37
The estimate of total folate intake was defined in each
study and included at least one of the following sources: nat-
ural sources of folate, folate-fortified food products and folate
supplementation. The study-specific definition of total folate
intake represented the most accurate proxy of the real intake
of folate in each population considered. In detail, among the
ten studies included, six reported folate estimates exclusively
from natural sources.28–31,35,37 Two other studies reported
folate estimates from natural sources, as well as from other
combined sources (i.e., natural food sources, folate-fortified
food products and folate supplementation)34,36 and two stud-
ies reported folate estimates exclusively from natural sources
and combined folate supplementation.32,33
Statistical analysis
The main analyses were based on total folate intake, defined
as the most complete information on folate intake reported
in each of the ten studies. A secondary analysis was based on
those studies (eight studies) providing information on the
natural sources of dietary folate only.28–31,34–37 For all the
analyses, we calculated the study-specific quintiles for folate
intake among controls. The study-specific cutoff values are
listed in Table 1.
The association between folate intake and OPC risk was
assessed by estimating the ORs and the corresponding 95%
CIs, using unconditional logistic regression model for each
case–control study, adjusted for age (quinquennia, categori-
cally), gender, education level (no formal education, less than
junior high school, some high school, high-school graduate,
vocational/some college and college graduate/postgraduate),
race/ethnicity (non-Hispanic White, Black, Hispanic/Latino,
Asian and other), cigarette smoking (never, 1–10, 11–20,
21–30, 31–40, 41–50, >50 pack-years), alcohol drinking
(nondrinkers, 0 to <1, 1 to <3, 3 to <5, 5 drinks/day)
and total energy intake (continuous).
The pooled effect estimates from all studies were esti-
mated with fixed-effects and random-effects logistic regres-
sion models.38 We tested for heterogeneity between the
study-specific ORs by conducting a likelihood ratio test com-
paring a model that included the product terms between
each study (other than the reference study) and the variable
of interest and a model without product terms, for the risk of
oral cavity and pharyngeal cancers combined and for that of
each anatomical subsite. We used the random-effects38 esti-
mates when heterogeneity was detected (p< 0.10), and the
fixed-effects estimates otherwise. We quantified inconsisten-
cies across studies and their impact on the analysis by using
Cochrane’s Q and the I2 statistic.39,40
We also conducted a sensitivity analysis in which each
study was excluded one at a time to ensure that the magni-
tude of the overall estimates was not dependent on any spe-
cific study. Subgroup analyses were also conducted by
stratifying the results for total folate intake according to age,
gender, geographic region, education level, study design, can-
cer subsite, body mass index, tobacco status and alcohol
drinking status.
Effect measure modification was evaluated by testing for
deviation from a multiplicative interaction model, using the
log-likelihood ratio test to compare the fit of logistic models
with and without an interaction term. Biological interaction
between alcohol, tobacco smoking and total folate intake was
estimated using departure from additivity of effects as the cri-
terion of interaction as proposed by Rothman.41 To quantify
the amount of interaction, the attributable proportion (AP)
owing to interaction was calculated as described by Ander-
sson et al.42 The AP owing to interaction is the proportion of
individuals among those exposed to the two interacting fac-
tors that is attributable to the interaction per se and it is
equal to 0 in the absence of a biological interaction.
Data analyses were conducted using SAS version 9.2 (SAS
Institute, Cary, NC) statistical software.
Results
Among the ten studies included, three were conducted in
Europe (26% of total cases and 33% of controls), six in North
America (65% of total cases and 44% of controls) and one in
Japan (9% of total cases and 23% of controls). Three studies
were based on cancer registries, whereas the remaining ones
were hospital-based case–control studies (Table 1). Table 2
summarizes the characteristics of the study population, which
included a total of 13,133 men and 5,233 women (26.7% of
cases and 29.2% of all controls were women). In total, more
than 78% of cases and 68% of controls were non-Hispanic
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white. Cases were more likely cigarette smokers and alcohol
drinkers than controls (Table 2).
The associations between total folate and folate from natu-
ral sources only and OPC risk are summarized in Table 3.
Considering the ten studies included in the total folate intake
analysis, the overall ORs of OPC were 0.78 (95% CI: 0.67–
0.91) for the second quintile, 0.77 (95% CI 0.61–0.96) for the
third quintile, 0.72 (95% CI: 0.51–1.01) for the fourth quintile
and 0.65 (95% CI: 0.43–0.99) for the fifth quintile compared
to the first quintile, with a significant p-value for trend and
heterogeneity between the studies. When the results were
stratified by anatomic subsite, the ORs for the highest versus
the lowest quintile of total folate intake were 0.57 (95% CI:
0.43–0.75) and 0.58 (95% CI: 0.42–0.81) for oral cavity and
NOS, respectively, with no evidence of heterogeneity across
studies. The OR for the highest versus the lowest quintile of
total folate intake was 0.74 (95% CI: 0.42–1.30) for orophar-
ynx/hypopharynx combined, with heterogeneity across stud-
ies (p5 0.06).
Considering the eight studies included in the folate intake
from natural sources only, the overall ORs of OPC were 0.75
(95% CI: 0.57–1.00) for the second quintile, 0.74 (95% CI:
0.50–1.10) for the third quintile, 0.70 (95% CI: 0.46–1.06) for
the fourth quintile and 0.72 (95% CI: 0.46–1.14) for the fifth
quintile compared to the first quintile, with heterogeneity
across studies (p< 0.01). When the results were stratified by
anatomic subsite, the ORs for the highest versus the lowest
quintile of natural folate intake were 0.64 (95% CI: 0.45–
0.91), 0.79 (95% CI: 0.44–1.43) and 0.69 (95% CI: 0.36–1.32)
for oral cavity, oropharynx/hypopharynx combined and NOS,
respectively, with evidence of heterogeneity across the studies
for the latter two subsites.
Table 2. Distribution of OPC cases and controls according to the
selected variables1 in the ten studies included in the INHANCE
Consortium
OPC cases Controls
n % n %
Age (years)
<40 237 4.6 739 5.6
40–44 228 4.5 625 4.7
45–49 526 10.3 1,043 7.9
50–54 785 15.3 1,879 14.2
55–59 953 18.6 2,261 17.1
60–64 814 15.9 2,148 16.2
65–69 734 14.3 2,087 15.7
70–74 542 10.5 1,644 12.4
75 308 6.0 821 6.2
p (v2 test) <0.0001
Sex
Men 3,753 73.3 9,380 70.8
Women 1,369 26.7 3,864 29.2
p (v2 test) 0.001
Race/ethnicity
Non-Hispanic white 4,006 78.3 9,064 68.6
Black 484 9.5 627 4.8
Hispanic/Latino 122 2.4 308 2.3
Asian 466 9.1 3,166 24.0
Other 37 0.7 48 0.3
p (v2 test) <0.0001
Education
No formal 235 4.6 716 5.4
Less than junior high school 1,117 21.8 4,088 30.9
Some high school 1,064 20.8 2,003 15.1
High-school graduate 764 14.9 1,638 12.4
Vocational school,
some college
1,317 25.7 2,749 20.8
College graduate/
postgraduate
627 12.2 2,046 15.4
p (v2 test) <0.0001
Cigarette smoking (pack-years)
Never smokers 919 18.2 5,239 40.2
1–10 356 7.1 1,788 13.7
11–20 406 8.0 1,422 10.9
21–30 583 11.6 1,248 9.6
31–40 633 12.6 1,136 8.6
41–50 594 11.8 778 6.0
>50 1,546 30.7 1,436 11.0
p (v2 test) <0.0001
Alcohol intake (drinks/die)
Nondrinkers 646 13.0 3,303 25.6
Table 2. Distribution of OPC cases and controls according to the
selected variables in the ten studies included in the INHANCE Con-
sortium (Continued)
OPC cases Controls
n % n %
>0 to <1 1,143 22.9 4,300 33.4
1 to <3 1,051 21.1 3,035 23.5
3 to <5 710 14.3 1,255 9.7
5 1,425 28.7 1,001 7.8
p (v2 test) <0.0001
Body mass index (kg/m2)
<25 2,942 59.4 6,436 48.9
25 2,014 40.6 6,721 51.1
p (v2 test) <0.0001
Total energy intake (kcal/die)
Mean6SD 1,58461,232 1,2836939
p (t-test) <0.0001
1The sum does not add up to the total because of some missing
values.
E
pi
de
m
io
lo
gy
908 Folate intake and the risk of OPC
Int. J. Cancer: 136, 904–914 (2015) VC 2014 UICC
Ta
b
le
3
.
A
ss
o
ci
a
ti
o
n
s
b
e
tw
e
e
n
fo
la
te
in
ta
k
e
a
n
d
ri
sk
o
f
O
P
C
,
o
ve
ra
ll
a
n
d
st
ra
ti
fi
e
d
b
y
a
n
a
to
m
ic
si
te
.
IN
H
A
N
C
E
C
o
n
so
rt
iu
m
O
P
C
O
ra
l
ca
vi
ty
O
ro
p
h
a
ry
n
x/
h
yp
o
p
h
a
ry
n
x
N
O
S
1
C
o
n
tr
o
ls
(n
)
C
a
se
s
(n
)
O
R
2
(9
5
%
C
I)
C
a
se
s
O
R
2
(9
5
%
C
I)
C
a
se
s
O
R
2
(9
5
%
C
I)
C
a
se
s
O
R
2
(9
5
%
C
I)
To
ta
l
fo
la
te
in
ta
ke
(t
e
n
st
u
d
ie
s
in
cl
u
d
e
d
3
)
I
Q
u
in
ti
le
4
2
,4
2
5
1
,0
0
9
1
(R
e
f)
3
4
2
1
(R
e
f)
4
9
1
1
(R
e
f)
1
7
6
1
II
Q
u
in
ti
le
2
,4
2
0
7
9
6
0
.7
8
(0
.6
7
–
0
.9
1
)
2
6
0
0
.7
4
(0
.6
0
–
0
.9
2
)
3
8
3
0
.7
7
(0
.6
2
–
0
.9
6
)
1
5
3
0
.8
9
(0
.6
9
–
1
.1
5
)
II
I
Q
u
in
ti
le
2
,4
2
9
8
5
9
0
.7
7
(0
.6
1
–
0
.9
6
)
2
5
5
0
.6
5
(0
.5
2
–
0
.8
1
)
4
4
1
0
.8
4
(0
.6
0
–
1
.1
7
)
1
6
3
0
.8
4
(0
.6
4
–
1
.1
0
)
IV
Q
u
in
ti
le
2
,4
3
5
8
6
0
0
.7
2
(0
.5
1
–
1
.0
1
)
2
6
6
0
.6
4
(0
.5
0
–
0
.8
2
)
4
2
2
0
.7
3
(0
.4
7
–
1
.1
6
)
1
7
2
0
.8
7
(0
.6
6
–
1
.1
5
)
V
Q
u
in
ti
le
2
,4
3
1
9
5
1
0
.6
5
(0
.4
3
–
0
.9
9
)
2
8
6
0
.5
7
(0
.4
3
–
0
.7
5
)
5
1
6
0
.7
4
(0
.4
2
–
1
.3
0
)
1
4
9
0
.5
8
(0
.4
2
–
0
.8
1
)
M
is
si
n
g
1
,1
0
9
6
5
2
2
0
4
3
1
8
1
3
0
To
ta
l
1
3
,2
4
9
5
,1
2
7
1
,6
1
3
2
,5
7
1
9
4
3
p
-V
a
lu
e
fo
r
tr
e
n
d
0
.0
4
<
0
.0
1
0
.2
8
<
0
.0
1
p
-V
a
lu
e
fo
r
h
e
te
ro
g
e
n
e
it
y
b
e
tw
e
e
n
st
u
d
ie
s
0
.0
4
0
.7
4
0
.0
6
0
.2
4
Fo
la
te
in
ta
ke
fr
o
m
n
a
tu
ra
l
so
u
rc
e
s
o
n
ly
(e
ig
h
t
st
u
d
ie
s
in
cl
u
d
e
d
5
)
I
Q
u
in
ti
le
3
2
,1
5
6
7
8
1
1
(R
e
f)
2
4
1
1
(R
e
f)
4
1
0
1
(R
e
f)
1
3
0
1
(R
e
f)
II
Q
u
in
ti
le
2
,1
4
2
6
0
6
0
.7
5
(0
.5
7
–
1
.0
0
)
1
8
9
0
.7
3
(0
.5
7
–
0
.9
4
)
2
9
8
0
.7
5
(0
.5
5
–
1
.0
3
)
1
1
9
0
.8
6
(0
.5
5
–
1
.3
6
)
II
I
Q
u
in
ti
le
2
,1
5
5
6
2
6
0
.7
4
(0
.5
0
–
1
.1
0
)
1
8
4
0
.7
2
(0
.5
5
–
0
.9
5
)
3
1
4
0
.7
4
(0
.4
7
–
1
.1
7
)
1
2
8
0
.9
3
(0
.4
8
–
1
.8
0
)
IV
Q
u
in
ti
le
2
,1
6
2
6
2
1
0
.7
0
(0
.4
6
–
1
.0
6
)
1
7
4
0
.6
3
(0
.4
7
–
0
.8
5
)
3
3
1
0
.7
1
(0
.4
2
–
1
.2
0
)
1
1
6
0
.8
3
(0
.4
5
–
1
.5
2
)
V
Q
u
in
ti
le
2
,1
6
0
6
9
6
0
.7
2
(0
.4
6
–
1
.1
4
)
1
9
5
0
.6
4
(0
.4
5
–
0
.9
1
)
3
8
9
0
.7
9
(0
.4
4
–
1
.4
3
)
1
1
2
0
.6
9
(0
.3
6
–
1
.3
2
)
M
is
si
n
g
1
,0
3
0
5
8
0
1
6
9
2
9
3
1
1
8
To
ta
l
1
1
,8
0
5
3
,9
1
0
1
,1
5
2
2
,0
3
5
7
2
3
p
-V
a
lu
e
fo
r
tr
e
n
d
0
.0
8
<
0
.0
1
0
.1
9
0
.3
1
p
-V
a
lu
e
fo
r
h
e
te
ro
g
e
n
e
it
y
b
e
tw
e
e
n
st
u
d
ie
s
<
0
.0
1
0
.7
2
0
.0
2
0
.0
2
1
N
O
S
,
n
o
t
o
th
e
rw
is
e
sp
e
ci
fi
e
d
.
2
R
a
n
d
o
m
-e
ff
e
ct
s
e
st
im
a
te
s
w
e
re
u
se
d
w
h
e
n
h
e
te
ro
g
e
n
e
it
y
w
a
s
d
e
te
ct
e
d
(p
<
0
.1
0
)
a
n
d
fi
xe
d
-e
ff
e
ct
s
o
th
e
rw
is
e
.
A
d
ju
st
e
d
fo
r
a
g
e
,
g
e
n
d
e
r,
ra
ce
/e
th
n
ic
it
y,
e
d
u
ca
ti
o
n
,
st
u
d
y,
ci
g
a
re
tt
e
sm
o
k
in
g
(p
a
ck
-
ye
a
rs
),
a
lc
o
h
o
l
in
ta
k
e
a
n
d
to
ta
l
e
n
e
rg
y
in
ta
k
e
.
3
S
tu
d
ie
s
in
cl
u
d
e
d
R
e
fs
.
2
8
–
3
7
.
4
C
a
lc
u
la
ti
o
n
o
f
cu
to
ff
s
fo
r
q
u
in
ti
le
w
a
s
b
a
se
d
o
n
th
e
d
is
tr
ib
u
ti
o
n
o
f
co
n
tr
o
ls
in
e
a
ch
st
u
d
y
(s
tu
d
y
sp
e
ci
fi
c)
.
5
S
tu
d
ie
s
in
cl
u
d
e
d
R
e
fs
.
2
8
–
3
1
,3
4
–
3
7
.
E
pi
de
m
io
lo
gy
Galeone et al. 909
Int. J. Cancer: 136, 904–914 (2015) VC 2014 UICC
The forest plots show the pooled and study-specific OR
estimates for the associations between the highest and the
lowest quintile of total folate intake, considering all cancer
sites combined and separately (Fig. 1). Out of the ten stud-
ies, the ORs of OPC were below unity in eight studies
(significant in four) and above unity in two studies
(nonsignificant).
Table 4 lists the ORs of OPC for the highest versus the
lowest quintile of total folate intake according to the selected
covariates. There was little evidence of notable effect modifi-
cation, except for a stronger inverse association in the
hospital-based studies (OR5 0.52; 95% CI: 0.40–0.69) com-
pared to the population-based ones (OR5 0.80; 95% CI:
0.63–1.01) (for heterogeneity, p5 0.02).
The analysis of interaction between total folate intake and
alcohol reported an OR of 4.05 (95% CI: 3.43–4.79) for heavy
drinkers with a low intake of folate, compared to subjects
with low alcohol and intermediate/high total folate intake
(for interaction, p5 0.75). Using the estimated ORs listed in
Table 5, the AP owing to interaction is (4.052
1.322 3.281 1)/4.055 11.1% (95% CI: 1.4–20.8%). Thus, we
estimate that 11.1% of OPC cases occurring among heavy
drinkers with low folate intake was attributable to biological
interaction (synergy). As for the interaction between tobacco
smoking and folates, we reported an OR of 2.73 (95% CI:
2.34–3.19) for those ever tobacco users with a low folate
intake, compared to subjects with never tobacco users and
intermediate/high total folate intake (for interaction,
p5 0.90). The AP owing to interaction is (2.732 1.33
2 2.111 1)/2.735 10.6% (95% CI: 0.4–20.8%), suggesting
that around 11% of OPC cases occurring among those ever
smokers and with low folate levels occurred because of the
interaction among the risk factors.
Discussion
This pooled analysis of ten case–control studies including
5,127 OPC cases provided evidence of an inverse association
between folate intake and OPC risk. The estimated associa-
tion was stronger for oral cavity cancer, with more than 40%
risk reduction for the highest quintile of folate intake, than
Figure 1. Study-specific and pooled estimates of OPC (a), oral cavity (b), oropharynx/hypopharynx (c) and NOS (d) cancer for the highest
versus the lowest quintile of total folate intake. INHANCE Consortium.
E
pi
de
m
io
lo
gy
910 Folate intake and the risk of OPC
Int. J. Cancer: 136, 904–914 (2015) VC 2014 UICC
Table 4. Distribution of cases of OPC and controls, and corresponding OR1 and 95% CI, for the highest quintile of total folate intake versus
the lowest one in strata of selected covariates. INHANCE Consortium
OPC
Cases2 n:n Controls2 n:n OR (95% CI)
p-Value for
heterogeneity
between studies
Age (years)
<55 350:348 810:751 0.69 (0.40–1.20) <0.01
55 659:603 1,615:1,680 0.70 (0.44–1.12) 0.03
p-Value for heterogeneity between strata 0.97
Gender
Men 674:769 1,637:1,820 0.60 (0.37–0.97) 0.03
Women 335:182 788:611 0.80 (0.55–1.16) 0.23
p-Value for heterogeneity between strata 0.36
Geographic region3
Europe 319:233 828:811 0.67 (0.37–1.19) 0.98
North America 577:667 1,010:1,020 0.73 (0.58–0.90) 0.22
Asia 113:51 587:600 0.51 (0.35–0.75) –
p-Value for heterogeneity between strata 0.29
Education
<high school graduate 325:235 898:908 0.57 (0.40–0.80) 0.24
high school graduate 684:716 1,527:1,523 0.71 (0.57–0.87) 0.21
p-Value for heterogeneity between strata 0.28
Study design
Hospital based 551:387 1,663:1,664 0.52 (0.40–0.69) 0.66
Population based 457:564 761:767 0.80 (0.63–1.01) 0.46
p-Value for heterogeneity between strata 0.02
Body mass index (kg/m2)4
<25 638:542 1,222:1,156 0.61 (0.48–0.79) 0.59
25 339:394 1,186:1,262 0.61 (0.33–1.13) 0.03
p-Value for heterogeneity between strata 1.00
Tobacco consumption4,5
Never tobacco users 141:134 834:874 1.05 (0.48–2.28) <0.01
Light tobacco users 129:140 527:592 0.74 (0.48–1.14) 0.94
Heavy tobacco users 696:644 914:813 0.55 (0.43–0.71) 0.47
p-Value for heterogeneity between strata 0.19
Alcohol consumption6
Never drinkers 140:88 670:570 0.51 (0.32–0.82) 0.24
Light drinkers 438:359 1,266:1,300 0.71 (0.35–1.44) 0.08
Heavy drinkers 431:504 489:561 0.59 (0.39–0.90) <0.01
p-Value for heterogeneity between strata 0.74
1Random-effects estimates were used when heterogeneity was detected, and fixed-effects otherwise. Adjusted for age, sex, race/ethnicity, educa-
tion, study, cigarette smoking (pack-years), alcohol intake and total energy intake (as appropriate). The reference category was the lowest quintile of
folate intake in each stratum. Calculation of cutoffs for quintile was based on the distribution of controls in each study (study specific).
2Number of subjects in the lowest quintile (I quintile): Number of subjects in the highest quintile (V quintile).
3Europe included two studies from Italy28,30 and from from Switzerland.29 North America included six studies.31–36 Asia included one study from Japan.37
4The sum does not add up to the total because of some missing values.
5Light tobacco users were smokers of 20 tobacco-years (combination of pack-years of cigarettes and pack-years of cigars/pipe in cigarette equiva-
lent), or subjects only snuffing tobacco. Heavy tobacco users were smokers of >20 tobacco-years or subjects ever chewing tobacco. Light drinkers
were defined as subjects who drank <3 drinks of alcoholic beverages per day and heavy drinkers 3 drinks per day.
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for oropharynx/hypopharynx. When pooling the eight studies
(3,910 OPC cases and 11,805 controls) detailing the intake of
natural folate from diet only, however, the inverse association
with OPC was no longer significant.
Only a few case–control studies with limited sample sizes
were considered on the association between (natural) folate
intake estimated from FFQ and OPC risk.7–11 Little or no
association was found in three epidemiological studies on
this issue conducted in the USA (OR5 0.7 for the highest vs.
lowest level of intake, in both men and women),9 Central
America (OR5 1.1, 95% CI: 0.6–2.2)11 and Uruguay
(OR5 1.3, 95% CI: 0.8–2.2).8 Two subsequent case–control
studies, one conducted in Italy and Switzerland from 1992 to
199710 and one in Uruguay from 1996 to 2004,7 found an
inverse association between folate intake and OPC risk, with
ORs, respectively, of 0.53 (95% CI: 0.40–0.69) and 0.49 (95%
CI, 0.24–0.98) for the highest versus lowest level of intake.
Another Italian study reported lower serum folate levels in
patients with head and neck squamous cell carcinoma (mean
value, 4.9 ng/mL) compared to control groups of nonsmokers
(mean5 9.7 ng/mL and p< 0.05) and smokers (mean5 9.1
ng/mL and p< 0.05).43
The results of our study suggest that total folate intake,
including fortified food and supplements, is inversely related
to OPC risk. Apart from UCLA study, the study-specific defi-
nition of total folate intake represented the most accurate
proxy of the real intake of folate in each population consid-
ered. In fact, these estimates take into account if supplements
and/or folate-fortified food products were commonly used in
each population during the enrollment study period. The
UCLA Study35 reported the estimates of natural folate only,
but it was conducted in a time and in a place where folate
fortification in staple foods was mandated (after January
1998) and dietary supplement use was popular. For this rea-
son, we performed a sensitivity analysis by excluding that
study. The pooled OR for the highest versus the lowest intake
of total folate was 0.62 (95% CI: 0.39–0.98) and was similar
to the pooled OR when considering all the ten studies
(pooled OR5 0.65; 95% CI: 0.43–0.99).
It was not possible, however, to determine how much of
this association was due to natural or synthetic folate, as
information on the intake of the two aforementioned sources
was detailed only in two studies, with no chance, therefore,
of performing any meaningful sensitivity analysis. Interest-
ingly, these studies are the only two that reported an OR of
>1 for the highest versus the lowest quintile of total folate
intake. As information on natural folate intake only was
available, we calculated the pooled OR for the highest versus
the lowest quintile of this folate source. This was 1.25 (95%
CI: 0.86–1.83), and thus not substantially different from the
corresponding pooled OR for total folate intake in these two
studies, that is 1.21 (95% CI: 0.87–1.68). Even if it is possible
that folic acid may exert a different effect than folate in its
natural form44 and it is known that the bioavailability of folic
acid from supplements is higher than the dietary one,45 the
few available data did not show important differences in risks
between the two sources of folate.
Owing to potential between-countries variations in folate
intake, we decided a priori to calculate study-specific quintiles
of folate intake. However, we also considered the relationship
between OPC and folate intake using absolute cutoffs, based
on the distribution of all controls combined. Using this
approach, the ORs for subsequent quintiles, as compared to
the lowest one, were 0.69, 0.69, 0.65 and 0.63 for all OPC,
and the trend in risk was significant. The results were con-
sistent for oral cavity and oropharynx.
Mechanistic evidence provides support for an inverse
association between folate intake and cancer risk. Folate defi-
ciency may increase the risk of various type of cancers, par-
ticularly of the gastrointestinal tract,46 through impaired
DNA synthesis and disruption of DNA methylation that may
lead to protoconcogene activation.47 The folate pathway is
led by the 5,10-methylenetetrahydrofolate reductase gene
(MTHFR), which converts the 5,10 methylenetetrahydrofolate
to 5-methyltetrahydrofolate, the primary circulating form of
folate and a cosubstrate for homocysteine methylation to
methionine.48 A less active form of MTHFR is present
among the subject carriers of the homozygous C677T variant,
which is present in 30% of Caucasians.49 The subjects with
impaired enzyme activity have reduced folate concentrations,
higher serum homocysteine levels, and higher DNA hypome-
thylation compared to those carrying the wild-type allele.50
In line with the principle of Mendelian randomization, it is
expected that subjects with reduced MTHFR activity are at
higher risk of OPC in view of the reduced serum folate levels.
Table 5. ORs1 and 95% CIs of OPC according to total folate intake
and alcohol and tobacco consumption. INHANCE Consortium
Total folate intake2
Intermediate to high Low
Alcohol consumption3
Never and light
drinkers
1 (Ref) 1.32 (1.17–1.48)
Cases:controls 1,545:6,538 902:3,286
Heavy drinkers 3.28 (2.89–3.73) 4.05 (3.43–4.79)
Cases:controls 1,429:1,735 680:800
Tobacco consumption
Never tobacco users 1(Ref) 1.33 (1.09–1.61)
Cases:controls 429:3,059 241:1,414
Ever tobacco users 2.11 (1.84–2.42) 2.73 (2.34–3.19)
Cases:controls 2,471:4,799 1,299:2,435
1Adjusted for age, sex, race/ethnicity, education, study, cigarette smok-
ing (pack-years) and total energy intake.
2Based on the tertiles of intake. Calculation of cutoffs for tertile of total
folate intake was based on the distribution of controls in each study
(study specific).
3Light drinkers were defined as subjects who drank <3 drinks of alco-
holic beverages per day and heavy drinkers 3 drinks per day.
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The distribution of alleles in a population is expected to be
unrelated to the confounders that may distort observational
epidemiologic studies because of the random assignment of
alleles at the time of gamete formation.51 As such, if a func-
tional genetic variant such as C677T of the MTHFR is
strongly associated with a modifiable exposure (folic acid
intake), it can be used to retrieve an unbiased estimate of the
association of such exposure (e.g., dietary folate) with a dis-
ease (e.g., OPC). Two meta-analyses on the association
between MTHFR and OPC have been published so far, with
the results showing the absence of an increased risk of cancer
among those carrying the unfavorable gene variants which is
associated with low serum folate levels.52,53 Taken together,
the results of our study and those from the functional genetic
variant association studies suggest that although folate intake
is, in principle, beneficial toward the risk of OPC, this effect
might be differential according to the exact source of folate.
In our study, we reported an additional excess risk of
OPC among those with low folate intake who are also heavy
drinkers, which is in line with previous findings.10,17,18 It has
been reported that alcohol perturbs folate metabolism by
reducing folate absorption, increasing folate excretion or
inhibiting methionine synthase,14 and hence an additional
risk of OPC might be present among heavy drinkers with
low folate intake. Additionally, our results suggest the pres-
ence of biological interaction between cigarette tobacco
smoke and folates, which is in line with previous studies and
the biological significance of tobacco in inducing cellular pro-
liferation in aerodigestive tissues as a result of the tissue
damage.16 Assuming that the relationships studied are causal
and based on the definition of biological interaction between
two component causes,41,54 our results suggest that more
than 11% of OPC cases among heavy alcohol drinkers with a
low folate intake, and around 11% of OPC among those ever
smokers with low folate intake have arisen because of the
synergistic interaction among the two component causes.
Taken together, these results have important implications
from a public health point of view as they show that by
increasing folate intake at the population level, even in the
presence of harmful lifestyle behaviors (alcohol and tobacco),
a relevant proportion of OPC cancer might be prevented.
Although our study has its strengths, including its very
large size, its capacity to explore effect modification by sev-
eral characteristics and the stratified analyses according to
cancer subsites, it is not without limitations. First, we were
unable to dissect the effect of folate on OPC risk according
to the intake of supplements or fortified foods. Second, the
investigation might be affected by limitations of case–control
studies, including recall bias that generally leads to stronger
associations between factors and OPC cancer than in cohort
studies. On the other hand, changes in dietary habits after
interview could dilute the risks in cohort investigations. Fur-
thermore, we were able to adjust for energy intake in all the
studies, and thus reducing the effect of possible systematic
under- or over-reporting. Selection bias in case–control stud-
ies, especially hospital-based studies, is also a methodological
limitation. Therefore, the weaker association observed in
population-based studies may be more valid. Nevertheless,
hospital-based case–control studies have the advantage over
population-based investigations of a higher comparability of
information of cases and controls.55
With reference to confounding, we were able to adjust for
major recognized risk factors for OPC as well as for total
energy intake, but no information was available in the
INHANCE data, version 1.5, on HPV, which is a relevant
risk factor for oropharyngeal cancer. If anything, however,
the inverse association with folate was stronger for other
OPC sites.
Conclusions
In conclusion, findings from this large pooled analysis sug-
gest that high levels of folate intake may protect against the
risk of OPC, after controlling for potential confounding fac-
tors, though we cannot rule out selection bias in the hospital-
based case–control studies.
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